| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227831A2 Interferon gamma for the treatment of asthma |
| 08/07/2002 | EP1227826A2 Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine |
| 08/07/2002 | EP1227825A1 Isolation and expansion of human marrow stromal cells |
| 08/07/2002 | EP1227824A1 Transplant/implant device and method for its production |
| 08/07/2002 | EP1227821A1 Therapeutic compositions and methods of use thereof |
| 08/07/2002 | EP1227820A2 Oligosaccharide aldonic acids and their topical use |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227812A2 Topical nasal treatment using desloratadine |
| 08/07/2002 | EP0983259B1 Tocopherol esters and their cosmetic and pharmaceutical uses |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/07/2002 | EP0874843B1 Substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases |
| 08/07/2002 | EP0701434B1 Preparations containing silicon dioxide to improve the taste thereof |
| 08/07/2002 | EP0689434B1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 08/07/2002 | CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362884A Preventives/remedies for liver diseases |
| 08/07/2002 | CN1362881A Inflammatory mediation obtained from atractylodes lancea |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362238A Nano analgesic Rhizome corydalis medicine and its preparation |
| 08/07/2002 | CN1362220A Nano Anemarrhenae, phellodendri and Rehmanniae medicine and its preparation |
| 08/07/2002 | CN1362199A Nano girald daphne medicine and its preparation |
| 08/07/2002 | CN1362171A Nano notoginseng medicine and its preparation |
| 08/07/2002 | CN1362155A Nano antirheumatic medicine and its preparation |
| 08/07/2002 | CN1362154A Nano rheumatic osteodynia treating medicine and its preparation |
| 08/07/2002 | CN1362148A Nano meridian passage dredging medicine and its preparation |
| 08/07/2002 | CN1362134A Nano blood stasis arthralgia treating medicine and its preparation |
| 08/07/2002 | CN1362116A Nano Chinese flowing quine medicine and its preparation |
| 08/07/2002 | CN1362103A Nano meridian passage dredging medicine and its preparation |
| 08/07/2002 | CN1362086A Nano Simiao medicine and its preparation |
| 08/07/2002 | CN1362082A Nano zhuifengtougu medicine and its preparation |
| 08/07/2002 | CN1362080A Nano zhengqing Fengtongning medicine and its preparation |
| 08/07/2002 | CN1362068A Rheumatoid disease treating capsule |
| 08/07/2002 | CN1088710C Water soluble repamycin esters |
| 08/07/2002 | CN1088587C Topical anti-inflammatory compositions containing piroxican |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429221 Inhibitors of tumor necrosis factor; used to treat cachexia, endotoxic shock, and retrovirus replication |
| 08/06/2002 | US6429214 Inhibitors of bone resorption |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6428787 TNF inhibitors for the treatment of retinal disorders |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059304A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059131A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059130A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059114A1 Lfa-1 antagonist compounds |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059106A1 Isoindole-imide compounds, compositions, and uses thereof |
| 08/01/2002 | WO2002059105A1 Styrene derivatives and process for production thereof |
| 08/01/2002 | WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | WO2002059083A2 Novel compounds |
| 08/01/2002 | WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | WO2002058721A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | WO2002058717A2 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 08/01/2002 | WO2002058716A2 Treatment of inflammatory bowel disease using growth factors |
| 08/01/2002 | WO2002058708A1 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 08/01/2002 | WO2002058704A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | WO2002058702A1 Urotensin-ii receptor antagonists |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002058692A2 Halogenated composition, method for preparing same and uses thereof |
| 08/01/2002 | WO2002058688A1 Use of neurotoxic substances in producing a medicament for treating joint pains |
| 08/01/2002 | WO2002058681A2 Use of rhein for preparing a medicine for treating a high level of il-1 |
| 08/01/2002 | WO2002058680A2 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders |
| 08/01/2002 | WO2002058670A1 Local anesthetic, and method of use |
| 08/01/2002 | WO2002058636A2 Novel cannabimimetic ligands |
| 08/01/2002 | WO2002058620A2 Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant |
| 08/01/2002 | WO2002051424A8 Drugs against articular failure |
| 08/01/2002 | WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 08/01/2002 | WO2002026733A3 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 08/01/2002 | WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 08/01/2002 | WO2002022166A3 Tweak receptor agonists as anti-angiogenic agents |
| 08/01/2002 | WO2002012227A3 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same |
| 08/01/2002 | WO2001096565A3 Binding agents: chimeric ligand/receptor proteins |
| 08/01/2002 | WO2001089536A3 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders |
| 08/01/2002 | WO2001089319A3 Tryptophan source from plants and uses therefor |
| 08/01/2002 | WO2001083554A3 Anti-inflammatory compounds and uses thereof |
| 08/01/2002 | WO2001082953A3 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 08/01/2002 | WO2001078654A3 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 08/01/2002 | WO2001072836A3 G-protein coupled receptors |
| 08/01/2002 | WO2001070738A3 Tri-aryl-substituted-ethane pde4 inhibitors |
| 08/01/2002 | WO2001064202A3 Tramadol for the treatment of functional gastrointestinal disorders |
| 08/01/2002 | WO2000077040A9 Human intracellular signaling molecules |
| 08/01/2002 | US20020103392 Corticoid-17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 08/01/2002 | US20020103340 Rab proteins |
| 08/01/2002 | US20020103335 Peptide derivatives |
| 08/01/2002 | US20020103334 Aprotinin variants having a net charge of +3 to -3 at pH 7 and with the amino acids Arg15 or Arg15-Ala17 in the binding region; serine protease inhibitor |
| 08/01/2002 | US20020103260 Combinations of formoterol and fluticasone proppionate for asthma |
| 08/01/2002 | US20020103259 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/01/2002 | US20020103245 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 08/01/2002 | US20020103242 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |